Answers are grounded in this paper and cite their sources.
The characterization of the viral life cycle facilitated the development of directly acting antiviral drugs. Among those, several inhibitors of the viral RNA-dependent RNA polymerase have proven effectiveness in clinical trials. The characteristics of different nucleos(t)ide and non-nucleoside polymerase inhibitors, as well as their clinical applications and combinations with other classes of directly acting antiviral drugs are reviewed herein.
No takes yet. Share an insight, caveat, or question.
Gerber et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: